• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATION Back to Search Results
Model Number NEUROSTAR 3.0
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Mental, Emotional or Behavioural Problem (4430)
Event Date 05/29/2022
Event Type  Injury  
Event Description
Healthcare professional reported that a patient with severe depression had attempted suicide after 8th treatment with tms.Patient was hospitalized and transferred to a psychiatric unit.
 
Manufacturer Narrative
Suicidal ideation is not an uncommon symptom of major depressive disorder.Additionally the patient is reported to be on bupropion which may cause some people to have suicidal thoughts and tendencies.Due to these confounding facts, it is impossible to determine the cause of the patient's condition.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR ADVANCED THERAPY
Type of Device
TRANSCRANIAL MAGNETIC STIMULATION
Manufacturer (Section D)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer Contact
robin fatzinger
3222 phoenixville pike
malvern, PA 19355
6109814027
MDR Report Key15138106
MDR Text Key296957577
Report Number3004824012-2022-00007
Device Sequence Number1
Product Code OBP
UDI-Device Identifier00869378000117
UDI-Public00869378000117
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K161519
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/01/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEUROSTAR 3.0
Device Catalogue Number81-02315-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/06/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
BUPROPION 150 MGPROZAC 60 MG
Patient Outcome(s) Life Threatening;
Patient Age53 YR
Patient SexFemale
-
-